Aipass Biotech Q4 2025 Financial Report
Aipass Biotech (Company Code: 6918) reported strong financial results for Q4 2025, with basic EPS of NT.16, revenue of NT36 million, and net profit after tax of NT70 million.
📋 Article Processing Timeline
- 📰 Published: December 1, 2025 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (3047h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:21 (16h 21m after Collected)
Company Code: 6918 Company Name: Aipass Biotech Co., Ltd. Industry: Biotechnology and Medical Care Year/Quarter: 2025 Q4 Basic Earnings Per Share: NT.16 Operating Revenue: NT36 million Net Profit After Tax: NT70 million